Krystal Biotech Inc (KRYS)
Receivables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 55,764 | 498 | — | — | — |
| Receivables | US$ in thousands | 42,040 | — | — | — | — |
| Receivables turnover | 1.33 | — | — | — | — |
December 31, 2023 calculation
Receivables turnover = Revenue ÷ Receivables
= $55,764K ÷ $42,040K
= 1.33
The receivables turnover ratio for Krystal Biotech Inc as of December 31, 2023, is 1.33. This indicates that the company collected its accounts receivable approximately 1.33 times during the year. A higher receivables turnover ratio generally suggests that the company is efficient in collecting outstanding payments from its customers. However, it is important to compare this ratio to industry benchmarks and historical data to gain a deeper understanding of Krystal Biotech's performance in managing its receivables effectively. The absence of data for the previous years limits the ability to identify trends or changes in the company's collection efficiency over time. Further analysis and comparison with industry peers would provide more insights into the company's receivables management practices and overall financial health.
Peer comparison
Dec 31, 2023